{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:04Z","timestamp":1792000984669,"version":"4.4.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/ncprheum0681","type":"journal-article","created":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T11:13:02Z","timestamp":1199358782000},"page":"34-42","source":"Crossref","is-referenced-by-count":268,"title":["Primer: inflammasomes and interleukin 1\u03b2 in inflammatory disorders"],"prefix":"10.1038","volume":"4","author":[{"given":"Leigh D","family":"Church","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncprheum0681_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/09680519050110060301","volume":"11","author":"JH Fritz","year":"2005","unstructured":"Fritz JH  et al. (2005) How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J Endotoxin Res 11: 390\u2013394","journal-title":"J Endotoxin Res"},{"key":"BFncprheum0681_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.it.2005.06.004","volume":"26","author":"F Martinon","year":"2005","unstructured":"Martinon F  et al. (2005) NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26: 447\u2013454","journal-title":"Trends Immunol"},{"key":"BFncprheum0681_CR3","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.1073\/pnas.81.24.7907","volume":"81","author":"PE Auron","year":"1984","unstructured":"Auron PE  et al. (1984) Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 81: 7907\u20137911","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0681_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF02427283","volume":"29","author":"T Mandrup-Poulsen","year":"1986","unstructured":"Mandrup-Poulsen T  et al. (1986) Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 29: 63\u201367","journal-title":"Diabetologia"},{"key":"BFncprheum0681_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F  et al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237\u2013241","journal-title":"Nature"},{"key":"BFncprheum0681_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00281-006-0015-6","volume":"27","author":"LD Church","year":"2006","unstructured":"Church LD  et al. (2006) Hereditary auto-inflammatory disorders and biologics. Springer Semin Immunopathol 27: 494\u2013508","journal-title":"Springer Semin Immunopathol"},{"key":"BFncprheum0681_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coi.2005.11.012","volume":"18","author":"LA O'Neill","year":"2006","unstructured":"O'Neill LA (2006) How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18: 3\u20139","journal-title":"Curr Opin Immunol"},{"key":"BFncprheum0681_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(85)90275-2","volume":"42","author":"KV Anderson","year":"1985","unstructured":"Anderson KV  et al. (1985) Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42: 791\u2013798","journal-title":"Cell"},{"key":"BFncprheum0681_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov R  et al. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394\u2013397","journal-title":"Nature"},{"key":"BFncprheum0681_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"P Matzinger","year":"2002","unstructured":"Matzinger P (2002) The danger model: a renewed sense of self. Science 296: 301\u2013305","journal-title":"Science"},{"key":"BFncprheum0681_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shi","year":"2003","unstructured":"Shi Y  et al. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516\u2013521","journal-title":"Nature"},{"key":"BFncprheum0681_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri1788","volume":"6","author":"JP Ting","year":"2006","unstructured":"Ting JP  et al. (2006) CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 6: 183\u2013195","journal-title":"Nat Rev Immunol"},{"key":"BFncprheum0681_CR13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/ni1412","volume":"7","author":"JH Fritz","year":"2006","unstructured":"Fritz JH  et al. (2006) Nod-like proteins in immunity, inflammation and disease. Nat Immunol 7: 1250\u20131257","journal-title":"Nat Immunol"},{"key":"BFncprheum0681_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nri1997","volume":"7","author":"S Mariathasan","year":"2007","unstructured":"Mariathasan S  et al. (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7: 31\u201340","journal-title":"Nat Rev Immunol"},{"key":"BFncprheum0681_CR15","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1074\/jbc.C200673200","volume":"278","author":"N Inohara","year":"2003","unstructured":"Inohara N  et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278: 5509\u20135512","journal-title":"J Biol Chem"},{"key":"BFncprheum0681_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y  et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603\u2013606","journal-title":"Nature"},{"key":"BFncprheum0681_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1103685","volume":"307","author":"S Maeda","year":"2005","unstructured":"Maeda S  et al. (2005) Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307: 734\u2013738","journal-title":"Science"},{"key":"BFncprheum0681_CR18","first-page":"1097","volume":"59","author":"G Tromp","year":"1996","unstructured":"Tromp G  et al. (1996) Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 59: 1097\u20131107","journal-title":"Am J Hum Genet"},{"key":"BFncprheum0681_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng720","volume":"29","author":"C Miceli-Richard","year":"2001","unstructured":"Miceli-Richard C  et al. (2001) CARD15 mutations in Blau syndrome. Nat Genet 29: 19\u201320","journal-title":"Nat Genet"},{"key":"BFncprheum0681_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/sj.ejhg.5201404","volume":"13","author":"MM van Duist","year":"2005","unstructured":"van Duist MM  et al. (2005) A new CARD15 mutation in Blau syndrome. Eur J Hum Genet 13: 742\u2013747","journal-title":"Eur J Hum Genet"},{"key":"BFncprheum0681_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","volume":"105","author":"N Kanazawa","year":"2005","unstructured":"Kanazawa N  et al. (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105: 1195\u20131197","journal-title":"Blood"},{"key":"BFncprheum0681_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0065-2776(08)60389-2","volume":"70","author":"H Okamura","year":"1998","unstructured":"Okamura H  et al. (1998) Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70: 281\u2013312","journal-title":"Adv Immunol"},{"key":"BFncprheum0681_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J  et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479\u2013490","journal-title":"Immunity"},{"key":"BFncprheum0681_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere V  et al. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 104: 282\u2013287","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0681_CR25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","volume":"20","author":"L Agostini","year":"2004","unstructured":"Agostini L  et al. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle\u2013Wells autoinflammatory disorder. Immunity 20: 319\u2013325","journal-title":"Immunity"},{"key":"BFncprheum0681_CR26","doi-asserted-by":"publisher","first-page":"21924","DOI":"10.1074\/jbc.M401178200","volume":"279","author":"TA Dowds","year":"2004","unstructured":"Dowds TA  et al. (2004) Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem 279: 21924\u201321928","journal-title":"J Biol Chem"},{"key":"BFncprheum0681_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/sj.cdd.4402038","volume":"14","author":"F Martinon","year":"2007","unstructured":"Martinon F  et al. (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10\u201322","journal-title":"Cell Death Differ"},{"key":"BFncprheum0681_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1998.tb08307.x","volume":"856","author":"CA Dinarello","year":"1998","unstructured":"Dinarello CA (1998) Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 856: 1\u201311","journal-title":"Ann NY Acad Sci"},{"key":"BFncprheum0681_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F  et al. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 417\u2013426","journal-title":"Mol Cell"},{"key":"BFncprheum0681_CR30","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.cub.2004.10.027","volume":"14","author":"F Martinon","year":"2004","unstructured":"Martinon F  et al. (2004) Identification of bacterial muramyl dipeptide as activator of the NALP3\/cryopyrin inflammasome. Curr Biol 14: 1929\u20131934","journal-title":"Curr Biol"},{"key":"BFncprheum0681_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature04517","volume":"440","author":"TD Kanneganti","year":"2006","unstructured":"Kanneganti TD  et al. (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3. Nature 440: 233\u2013236","journal-title":"Nature"},{"key":"BFncprheum0681_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","volume":"440","author":"S Mariathasan","year":"2006","unstructured":"Mariathasan S  et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228\u2013232","journal-title":"Nature"},{"key":"BFncprheum0681_CR33","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","volume":"14","author":"V Petrilli","year":"2007","unstructured":"Petrilli V  et al. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583\u20131589","journal-title":"Cell Death Differ"},{"key":"BFncprheum0681_CR34","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.cub.2007.05.074","volume":"17","author":"L Feldmeyer","year":"2007","unstructured":"Feldmeyer L  et al. (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17: 1140\u20131145","journal-title":"Curr Biol"},{"key":"BFncprheum0681_CR35","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.4049\/jimmunol.171.12.6329","volume":"171","author":"W O'Connor Jr","year":"2003","unstructured":"O'Connor W Jr  et al. (2003) Cutting edge: CIAS1\/cryopyrin\/PYPAF1\/NALP3\/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. J Immunol 171: 6329\u20136333","journal-title":"J Immunol"},{"key":"BFncprheum0681_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.cdd.4401734","volume":"13","author":"JW Yu","year":"2006","unstructured":"Yu JW  et al. (2006) Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 13: 236\u2013249","journal-title":"Cell Death Differ"},{"key":"BFncprheum0681_CR37","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1073\/pnas.0602081103","volume":"103","author":"JJ Chae","year":"2006","unstructured":"Chae JJ  et al. (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 103: 9982\u20139987","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0681_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00005792-199807000-00005","volume":"77","author":"J Samuels","year":"1998","unstructured":"Samuels J  et al. (1998) Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 77: 268\u2013297","journal-title":"Medicine (Baltimore)"},{"key":"BFncprheum0681_CR39","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/sj.jid.5700819","volume":"127","author":"H Watanabe","year":"2007","unstructured":"Watanabe H  et al. (2007) Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 127: 1956\u20131963","journal-title":"J Invest Dermatol"},{"key":"BFncprheum0681_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","volume":"24","author":"FS Sutterwala","year":"2006","unstructured":"Sutterwala FS  et al. (2006) Critical role for NALP3\/CIAS1\/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317\u2013327","journal-title":"Immunity"},{"key":"BFncprheum0681_CR41","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.4049\/jimmunol.178.9.5411","volume":"178","author":"TT Pizarro","year":"2007","unstructured":"Pizarro TT  et al. (2007) Cloning IL-1 and the birth of a new era in cytokine biology. J Immunol 178: 5411\u20135412","journal-title":"J Immunol"},{"key":"BFncprheum0681_CR42","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1002\/art.22841","volume":"56","author":"CA Dinarello","year":"2007","unstructured":"Dinarello CA (2007) Mutations in cryopyrin: bypassing roadblocks in the caspase 1 inflammasome for interleukin-1beta secretion and disease activity. Arthritis Rheum 56: 2817\u20132822","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0681_CR43","doi-asserted-by":"publisher","first-page":"34495","DOI":"10.1074\/jbc.M101415200","volume":"276","author":"SH Lee","year":"2001","unstructured":"Lee SH  et al. (2001) Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 276: 34495\u201334500","journal-title":"J Biol Chem"},{"key":"BFncprheum0681_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0092-8674(00)00108-2","volume":"103","author":"EW Humke","year":"2000","unstructured":"Humke EW  et al. (2000) ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 103: 99\u2013111","journal-title":"Cell"},{"key":"BFncprheum0681_CR45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1042\/bj3420655","volume":"342","author":"RR Annand","year":"1999","unstructured":"Annand RR  et al. (1999) Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem J 342: 655\u2013665","journal-title":"Biochem J"},{"key":"BFncprheum0681_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/bj20030304","volume":"373","author":"C Stehlik","year":"2003","unstructured":"Stehlik C  et al. (2003) The PAAD\/PYRIN-only protein POP1\/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation. Biochem J 373: 101\u2013113","journal-title":"Biochem J"},{"key":"BFncprheum0681_CR47","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.4049\/jimmunol.178.6.3837","volume":"178","author":"F Bedoya","year":"2007","unstructured":"Bedoya F  et al. (2007) Pyrin-only protein 2 modulates NF-kappaB and disrupts ASC:CLR interactions. J Immunol 178: 3837\u20133845","journal-title":"J Immunol"},{"key":"BFncprheum0681_CR48","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1084\/jem.20050640","volume":"201","author":"CA Dinarello","year":"2005","unstructured":"Dinarello CA (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201: 1355\u20131359","journal-title":"J Exp Med"},{"key":"BFncprheum0681_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1182\/asheducation-2005.1.74","volume":"1","author":"DL Kastner","year":"2005","unstructured":"Kastner DL (2005) Hereditary periodic fever syndromes. Hematology Am Soc Hematol Educ Program 1: 74\u201381","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFncprheum0681_CR50","first-page":"484","volume":"66","author":"MF McDermott","year":"1999","unstructured":"McDermott MF (1999) Autosomal dominant recurrent fevers. Clinical and genetic aspects. Rev Rheum Engl Ed 66: 484\u2013491","journal-title":"Rev Rheum Engl Ed"},{"key":"BFncprheum0681_CR51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM  et al. (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle\u2013Wells syndrome. Nat Genet 29: 301\u2013305","journal-title":"Nat Genet"},{"key":"BFncprheum0681_CR52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/341357","volume":"71","author":"J Feldmann","year":"2002","unstructured":"Feldmann J  et al. (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71: 198\u2013203","journal-title":"Am J Hum Genet"},{"key":"BFncprheum0681_CR53","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/art.10509","volume":"46","author":"E Aganna","year":"2002","unstructured":"Aganna E  et al. (2002) Association of mutations in the NALP3\/CIAS1\/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46: 2445\u20132452","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0681_CR54","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/art.22842","volume":"56","author":"M Gattorno","year":"2007","unstructured":"Gattorno M  et al. (2007) Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 56: 3138\u20133148","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0681_CR55","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/art.20033","volume":"50","author":"PN Hawkins","year":"2004","unstructured":"Hawkins PN  et al. (2004) Spectrum of clinical features in Muckle\u2013Wells syndrome and response to anakinra. Arthritis Rheum 50: 607\u2013612","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0681_CR56","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","volume":"364","author":"HM Hoffman","year":"2004","unstructured":"Hoffman HM  et al. (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364: 1779\u20131785","journal-title":"Lancet"},{"key":"BFncprheum0681_CR57","first-page":"127","volume":"305","author":"S Brydges","year":"2006","unstructured":"Brydges S  et al. (2006) The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr Top Microbiol Immunol 305: 127\u2013160","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFncprheum0681_CR58","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.2135380100","volume":"100","author":"NG Shoham","year":"2003","unstructured":"Shoham NG  et al. (2003) Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 100: 13501\u201313506","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0681_CR59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.it.2004.07.007","volume":"25","author":"MF McDermott","year":"2004","unstructured":"McDermott MF (2004) A common pathway in periodic fever syndromes. Trends Immunol 25: 457\u2013460","journal-title":"Trends Immunol"},{"key":"BFncprheum0681_CR60","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So A  et al. (2007) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9: R28","journal-title":"Arthritis Res Ther"},{"key":"BFncprheum0681_CR61","unstructured":"McGonagle D  et al.: Successful treatment of resistant pseudogout with anakinra. Arthritis Rheum, in press"},{"key":"BFncprheum0681_CR62","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D  et al. (2006) A proposed classification of the immunological diseases. PLoS Med 3: e297","journal-title":"PLoS Med"},{"key":"BFncprheum0681_CR63","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V  et al. (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201: 1479\u20131486","journal-title":"J Exp Med"},{"key":"BFncprheum0681_CR64","first-page":"2071","volume":"31","author":"JW Verbsky","year":"2004","unstructured":"Verbsky JW  et al. (2004) Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J Rheumatol 31: 2071\u20132075","journal-title":"J Rheumatol"},{"key":"BFncprheum0681_CR65","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/0167-5699(94)90217-8","volume":"15","author":"F Colotta","year":"1994","unstructured":"Colotta F  et al. (1994) The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol Today 15: 562\u2013566","journal-title":"Immunol Today"},{"key":"BFncprheum0681_CR66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1074-7613(02)00514-9","volume":"18","author":"DE Smith","year":"2003","unstructured":"Smith DE  et al. (2003) The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 18: 87\u201396","journal-title":"Immunity"},{"key":"BFncprheum0681_CR67","first-page":"823","volume":"34","author":"AP Lotito","year":"2007","unstructured":"Lotito AP  et al. (2007) Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol 34: 823\u2013830","journal-title":"J Rheumatol"},{"key":"BFncprheum0681_CR68","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/art.10389","volume":"46","author":"N Maeno","year":"2002","unstructured":"Maeno N  et al. (2002) Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima  et al. Arthritis Rheum 46: 2539\u20132541","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0681_CR69","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","volume":"44","author":"M Kawashima","year":"2001","unstructured":"Kawashima M  et al. (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 44: 550\u2013560","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0681_CR70","first-page":"2422","volume":"30","author":"JH Choi","year":"2003","unstructured":"Choi JH  et al. (2003) Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 30: 2422\u20132427","journal-title":"J Rheumatol"},{"key":"BFncprheum0681_CR71","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG (1971) Still's disease in the adult. Ann Rheum Dis 30: 121\u2013133","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0681_CR72","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/art.21061","volume":"52","author":"AA Fitzgerald","year":"2005","unstructured":"Fitzgerald AA  et al. (2005) Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52: 1794\u20131803","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0681_CR73","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/01.rhu.0000089966.48691.7f","volume":"9","author":"A Rudinskaya","year":"2003","unstructured":"Rudinskaya A  et al. (2003) Successful treatment of a patient with refractory adult-onset still disease with anakinra. J Clin Rheumatol 9: 330\u2013332","journal-title":"J Clin Rheumatol"},{"key":"BFncprheum0681_CR74","unstructured":"Kotter I  et al.: Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum, in press"},{"key":"BFncprheum0681_CR75","unstructured":"de Koning HD  et al.: Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum, in press"},{"key":"BFncprheum0681_CR76","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1073\/pnas.0502854102","volume":"102","author":"CH Evans","year":"2005","unstructured":"Evans CH  et al. (2005) Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci USA 102: 8698\u20138703","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0681_CR77","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.4049\/jimmunol.175.4.2630","volume":"175","author":"JH Stack","year":"2005","unstructured":"Stack JH  et al. (2005) IL-converting enzyme\/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J Immunol 175: 2630\u20132634","journal-title":"J Immunol"},{"key":"BFncprheum0681_CR78","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"W Wannamaker","year":"2007","unstructured":"Wannamaker W  et al. (2007) (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl- butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther 321: 509\u2013516","journal-title":"J Pharmacol Exp Ther"},{"key":"BFncprheum0681_CR79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/RHU.0b013e31812e00a1","volume":"13","author":"LD Settas","year":"2007","unstructured":"Settas LD  et al. (2007) Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra). J Clin Rheumatol 13: 219\u2013220","journal-title":"J Clin Rheumatol"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0681","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:09:12Z","timestamp":1684444152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["BFncprheum0681"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0681","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}